Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

GENE:

TUBB3 (Tubulin beta 3 class III)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

TUBB3 overexpression	Prostate Cancer	TUBB3 overexpression	Prostate Cancer	abiraterone acetate Sensitive: C3 – Early Trials abiraterone acetate Sensitive : C3	abiraterone acetate Sensitive: C3 – Early Trials abiraterone acetate Sensitive : C3
TUBB3 overexpression	Gastric Cancer	TUBB3 overexpression	Gastric Cancer	docetaxel Resistant: C3 – Early Trials docetaxel Resistant : C3	docetaxel Resistant: C3 – Early Trials docetaxel Resistant : C3
TUBB3 expression	Peritoneal Cancer	TUBB3 expression	Peritoneal Cancer	bevacizumab + ixabepilone Resistant: C3 – Early Trials bevacizumab + ixabepilone Resistant : C3	bevacizumab + ixabepilone Resistant: C3 – Early Trials bevacizumab + ixabepilone Resistant : C3
TUBB3 expression	Fallopian Tube Cancer	TUBB3 expression	Fallopian Tube Cancer	bevacizumab + ixabepilone Resistant: C3 – Early Trials bevacizumab + ixabepilone Resistant : C3	bevacizumab + ixabepilone Resistant: C3 – Early Trials bevacizumab + ixabepilone Resistant : C3
TUBB3 expression	Ovarian Cancer	TUBB3 expression	Ovarian Cancer	bevacizumab + ixabepilone Resistant: C3 – Early Trials bevacizumab + ixabepilone Resistant : C3	bevacizumab + ixabepilone Resistant: C3 – Early Trials bevacizumab + ixabepilone Resistant : C3
TUBB3 deletion	Breast Cancer	TUBB3 deletion	Breast Cancer	cisplatin + cyclophosphamide Sensitive: C3 – Early Trials cisplatin + cyclophosphamide Sensitive : C3	cisplatin + cyclophosphamide Sensitive: C3 – Early Trials cisplatin + cyclophosphamide Sensitive : C3
TUBB3 overexpression	Cervical Cancer	TUBB3 overexpression	Cervical Cancer	eribulin mesylate Resistant: C3 – Early Trials eribulin mesylate Resistant : C3	eribulin mesylate Resistant: C3 – Early Trials eribulin mesylate Resistant : C3
TUBB3 underexpression	Non Small Cell Lung Cancer	TUBB3 underexpression	Non Small Cell Lung Cancer	carboplatin + paclitaxel Sensitive: C3 – Early Trials carboplatin + paclitaxel Sensitive : C3	carboplatin + paclitaxel Sensitive: C3 – Early Trials carboplatin + paclitaxel Sensitive : C3
TUBB3 overexpression	Non Small Cell Lung Cancer	TUBB3 overexpression	Non Small Cell Lung Cancer	cisplatin + gemcitabine Resistant: C3 – Early Trials cisplatin + gemcitabine Resistant : C3	cisplatin + gemcitabine Resistant: C3 – Early Trials cisplatin + gemcitabine Resistant : C3